BioCorRx BICX
OTC BICX
$0.25 +0.05 (+25.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

BioCorRx (BICX) Accumulated Expenses (2015 - 2026)

Updated

BioCorRx (BICX) recorded Accumulated Expenses of $530,375 in Q2 2026.

Analysis

BioCorRx (BICX) Accumulated Expenses (2015 - 2026) Analysis & Trends

At the end of FY2025, BioCorRx reported Accumulated Expenses of $495,530.

  • Annual Accumulated Expenses has a five-year compound annual growth rate of 388.0% (FY2020 to FY2025).
  • Across earlier years, Accumulated Expenses came in at $983.00 in FY2021 (+449.2%).
  • The Q2 2026 figure is the highest quarterly Accumulated Expenses in data going back to Q1 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 BioCorRx 4.32 Mn 3.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 530,375.00
Dec 31, 2025 495,530.00
Jun 30, 2022 1,652.00
Mar 31, 2022 1,292.00
Dec 31, 2021 983.00
Jun 30, 2021 299.00
Dec 31, 2020 179.00
Sep 30, 2020 107.00
Jun 30, 2020 36.00
Mar 31, 2017 220,000.00
Mar 31, 2015 1,052.00
API Access

BioCorRx Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BICX&period=max&api_key=YOUR_API_KEY